| Bioactivity | ICI D1542 is a selective and potent inhibitor of thromboxane A2 (TXA2) synthase and the thromboxane A2 receptor (TP-receptor). ICI D1542 is effective at preventing thrombus formation by redirection of arachidonic acid metabolism[1]. |
| Name | ICI D1542 |
| CAS | 147332-48-7 |
| Formula | C25H30N2O7 |
| Molar Mass | 470.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. S J McAuliffe, et al. Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dog. r J Pharmacol. 1993 Apr;108(4):901-6. |
ICI D1542
CAS: 147332-48-7 F: C25H30N2O7 W: 470.51
ICI D1542 is a selective and potent inhibitor of thromboxane A2 (TXA2) synthase and the thromboxane A2 receptor (TP-rece
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.